Group One Trading, L.P. Apellis Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.81 Billion
Q3 2025

A detailed history of Group One Trading, L.P. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 14,925 shares of APLS stock, worth $303,425. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,925

Previous 16,778 11.04%

Holding current value

$303,425

Previous $290,000 16.21%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$17.42 - $28.65 $32,279 - $53,088	-1,853 Reduced 11.04%	14,925 $337,000
Q2 2025 Aug 13, 2025	SELL	$16.36 - $23.0 $216,982 - $305,049	-13,263 Reduced 44.15%	16,778 $290,000
Q1 2025 May 14, 2025	BUY	$21.87 - $34.63 $656,996 - $1.04 Million	30,041 New	30,041 $656,000
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $214,973 - $306,732	7,454 Added 21.48%	42,153 $1.22 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $1.32 Million - $2.07 Million	34,699 New	34,699 $1.33 Million

Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $1.01 Million - $1.76 Million	27,221 Added 12.01%	253,905 $15.2 Million
Q3 2023 Nov 09, 2023	BUY	$23.65 - $89.22 $4.92 Million - $18.5 Million	207,866 Added 1104.61%	226,684 $8.62 Million
Q2 2023 Aug 09, 2023	BUY	$76.68 - $93.31 $1.07 Million - $1.3 Million	13,908 Added 283.26%	18,818 $1.71 Million
Q1 2023 May 12, 2023	SELL	$46.59 - $66.96 $2.14 Million - $3.07 Million	-45,913 Reduced 90.34%	4,910 $323,000
Q4 2022 Feb 09, 2023	BUY	$43.24 - $61.04 $2.2 Million - $3.1 Million	50,823 New	50,823 $2.63 Million
Q2 2022 Aug 11, 2022	SELL	$35.07 - $59.21 $1.04 Million - $1.76 Million	-29,723 Reduced 53.51%	25,823 $1.17 Million
Q1 2022 May 12, 2022	BUY	$35.46 - $54.12 $692,356 - $1.06 Million	19,525 Added 54.2%	55,546 $2.82 Million
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $2.14 Million - $3.43 Million	-69,731 Reduced 65.94%	36,021 $1.7 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $3.32 Million - $7.39 Million	105,752 New	105,752 $3.49 Million
Q4 2020 Feb 10, 2021	SELL	$30.79 - $57.2 $50,156 - $93,178	-1,629 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$25.89 - $33.65 $42,174 - $54,815	1,629 New	1,629 $49,000
Q4 2019 Feb 10, 2020	SELL	$22.1 - $30.8 $2,210 - $3,080	-100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$24.09 - $32.18 $2,409 - $3,218	100 New	100 $2,000

Others Institutions Holding APLS

# of Institutions

331

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Apellis Pharmaceuticals, Inc. Transaction History